99 related articles for article (PubMed ID: 21664098)
21. [Up-regulation of HOXA13 in esophageal squamous cell carcinoma of stage IIa and its effect on the prognosis].
Yan WP; Shen LY; Gu ZD; Chen KN
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):20-3. PubMed ID: 19145497
[TBL] [Abstract][Full Text] [Related]
22. Involvement of Cyr61 in the growth, invasiveness and adhesion of esophageal squamous cell carcinoma cells.
Xie JJ; Xu LY; Xie YM; Du ZP; Feng CH; Dong H; Li EM
Int J Mol Med; 2011 Mar; 27(3):429-34. PubMed ID: 21249313
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma.
Takatori H; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Setoyama T; Sasaki K; Tamotsu K; Owaki T; Ishigami S; Aikou T
Eur J Surg Oncol; 2008 Apr; 34(4):397-402. PubMed ID: 17553653
[TBL] [Abstract][Full Text] [Related]
24. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
25. Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma.
Hoshino M; Fukui H; Ono Y; Sekikawa A; Ichikawa K; Tomita S; Imai Y; Imura J; Hiraishi H; Fujimori T
Pathobiology; 2007; 74(1):15-21. PubMed ID: 17496429
[TBL] [Abstract][Full Text] [Related]
26. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
[TBL] [Abstract][Full Text] [Related]
28. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
[TBL] [Abstract][Full Text] [Related]
29. Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer.
Terashita Y; Ishiguro H; Haruki N; Sugiura H; Tanaka T; Kimura M; Shinoda N; Kuwabara Y; Fujii Y
Oncol Rep; 2004 Oct; 12(4):827-31. PubMed ID: 15375507
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of CD151 expression in esophageal squamous cell carcinoma with aggressive cell proliferation and invasiveness.
Suzuki S; Miyazaki T; Tanaka N; Sakai M; Sano A; Inose T; Sohda M; Nakajima M; Kato H; Kuwano H
Ann Surg Oncol; 2011 Mar; 18(3):888-93. PubMed ID: 20978946
[TBL] [Abstract][Full Text] [Related]
31. p53 expression and p21 expression are mutually exclusive in esophageal squamous cell carcinoma.
Hamada M; Naomoto Y; Shirakawa Y; Yamatsuji T; Noma K; Motoki T; Nobuhisa T; Okawa T; Haisa M; Gunduz M; Matsuoka J; Tanaka N
Oncol Rep; 2004 Jan; 11(1):57-63. PubMed ID: 14654903
[TBL] [Abstract][Full Text] [Related]
32. Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus.
Nozoe T; Oyama T; Takenoyama M; Hanagiri T; Sugio K; Yasumoto K
Clin Cancer Res; 2007 Jul; 13(14):4046-50. PubMed ID: 17634528
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
[TBL] [Abstract][Full Text] [Related]
34. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
[TBL] [Abstract][Full Text] [Related]
35. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma.
Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
Am J Clin Pathol; 2007 Dec; 128(6):1002-9. PubMed ID: 18024326
[TBL] [Abstract][Full Text] [Related]
36. Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus.
Takeuchi H; Ikeuchi S; Kitagawa Y; Shimada A; Oishi T; Isobe Y; Kubochi K; Kitajima M; Matsumoto S
J Gastroenterol Hepatol; 2007 Dec; 22(12):2222-7. PubMed ID: 18031385
[TBL] [Abstract][Full Text] [Related]
37. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
38. Cytoplasmic expression of type VII collagen is related to prognosis in patients with esophageal squamous cell carcinoma.
Baba Y; Iyama K; Honda S; Ishikawa S; Miyanari N; Baba H
Oncology; 2006; 71(3-4):221-8. PubMed ID: 17652943
[TBL] [Abstract][Full Text] [Related]
39. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma.
Sano A; Sakurai S; Kato H; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Sakamoto K; Sano T; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Oyama T; Kuwano H
Anticancer Res; 2009 Aug; 29(8):3375-80. PubMed ID: 19661359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
